Cargando…
Treatment outcome after failure of a first antiepileptic drug
OBJECTIVES: We assessed the likelihood of 12-month seizure remission and treatment failure after failure of a first antiepileptic drug, and identified factors influencing these outcomes. METHODS: SANAD (Standard and New Antiepileptic Drug) was a randomized controlled trial comparing monotherapy with...
Autores principales: | Bonnett, Laura J., Tudur Smith, Catrin, Donegan, Sarah, Marson, Anthony G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4142004/ https://www.ncbi.nlm.nih.gov/pubmed/24994842 http://dx.doi.org/10.1212/WNL.0000000000000673 |
Ejemplares similares
-
Breakthrough seizures—Further analysis of the Standard versus New Antiepileptic Drugs (SANAD) study
por: Bonnett, Laura J., et al.
Publicado: (2017) -
Risk of a seizure recurrence after a breakthrough seizure and the implications for driving: further analysis of the standard versus new antiepileptic drugs (SANAD) randomised controlled trial
por: Bonnett, L J, et al.
Publicado: (2017) -
Time to 12-month remission and treatment failure for generalised and unclassified epilepsy
por: Bonnett, Laura J, et al.
Publicado: (2014) -
Modelling seizure rates rather than time to an event within clinical trials of antiepileptic drugs
por: Bonnett, Laura J., et al.
Publicado: (2020) -
Anti-epileptic drug harms: issues for meta-analysis
por: Smith, Catrin Tudur, et al.
Publicado: (2011)